Grit Metals Corp. has appointed Ms. Dani Palahanova, CPA, as its new Chief Financial Officer and Corporate Secretary effective October 1, 2026. With over 20 years of experience in financial management and governance in public companies, especially in mineral exploration, Palahanova's leadership is expected to support Grit's exploration strategy and growth opportunities. She replaces Joel Leonard, who stepped down after 2.5 years. The company also granted her stock options as part of her compensation package. This move aims to bolster Grit's management team as it advances its lithium exploration projects in Finland near a major integrated lithium mine and production complex.
Grit Metals' leadership update is noted with Pluang market data as context. As of Oct 02, 2026 03:27 WIB, among 38 priced Basic Materials-sector US stocks on Pluang, 7 rose and 30 fell. Notable movers include LAC at USD 2.59 with a 1-day change of -1.52% and a Pluang order activity of 65% Sell / 35% Buy, and Barrick Gold Corp at USD 40.06 with 0% Sell / 100% Buy order activity. The most notable figure is Ecolab Inc. at USD 270.75 with 89% Sell / 11% Buy order activity and a typical hold time of 89 days.
Wells Fargo initiated coverage on BlackRock with an 'Overweight' rating, highlighting it as a good entry point for investors. Analysts expect BlackRock's Q3 earnings per share to rise to $14.25 from $11.55 a year ago, with revenue projected at $7.56 ...
Nike reported earnings per share of $0.48, beating estimates, but revenue fell short at $11.21 billion due to weak demand in Greater China and rising competition. The company issued a cautious fiscal 2027 outlook with EPS forecast between $1.15 and $...
NETSOL Technologies reported a record $20.7 million revenue in fiscal 2026 Q4, with net income rising 45.9% to $3.8 million. The company improved its gross margin to 63.6% and operating margin to 21.6%, reflecting enhanced profitability. For fiscal 2...
On October 1, 2026, Nexalin Technology surged 76.4% after securing a 10-year exclusive deal for its medical device in South America. Armada Acquisition Corp. II jumped 42.9% following shareholder approval of its merger with Evernorth, expected to clo...
Jefferies analyst Roger Song set a $150 price target for Nektar Therapeutics, suggesting a 219% upside from its $46.99 trading price. This comes after Nektar presented positive six-month Phase IIb trial results for its alopecia drug REZPEG, which als...
